News from NYU Langone Health NYU Langone Health Opens Ambulatory Center in Former Bloomingdales, Sears. (Becker's ASC Review)

Beckers ASC Review (1/31) reports, New York City-based NYU Langone Health has opened a 260,000-square-foot ambulatory center in Garden City, N.Y., in a former Bloomingdales and Sears building. The new facility is NYU Langone Healths largest ambulatory care site on Long Island, and contains 260 patient rooms, an expanded adult ophthalmology service and 32 clinical specialties, including cardiology, dermatology, endocrinology, gastroenterology, internal medicine, surgical specialties, OB-GYN, pediatrics, radiology and pulmonology.

Crains New York Business (2/1) reports that Andrew W. Brotman, MD, executive vice president and vice dean for clinical affairs and strategy, and chief clinical officer at NYU Langone Health indicated that the new facility emphasizes the trend of hospitals moving toward having more services provided by outpatient facilities, saying, We consider ourselves an ambulatory network with a few hospitals as opposed to a hospital network that adds on ambulatory . ... A vast majority of patients frankly dont need a hospital. Also reporting are the Radiology Business Journal (1/31) and 12-TV (1/31).

Beckers ASC Review (1/31) publishes a listicle of the top hospitals for gastrointestinal medical care in 20 states according to Healthgrades, including NYU Langone Healths Tisch Hospital in New York City. Also reporting in a second story is Beckers ASC Review (1/31).

CNN (1/30) Robert Montgomery, MD, DPhil, the H. Leon Pachter, MD, Professor of Surgery, chair, Department of Surgery, Division of Transplant Surgery, NYU Langone Transplant Institute at NYU Langone Health, who was the recipient of a heart transplant after seven cardiac arrests and still not deemed sick enough to be able to draw an organ, said, We need a sustainable, renewable source of organs from something else other than humans dying.

CNN (2/1) Access to medications for opioid use disorder has been an ongoing issue for people in the United States, said Noa Krawczyk, PhD, assistant professor, Center for Opioid Epidemiology and Policy, Department of Population Health at the NYU Grossman School of Medicine and a member of the Center for Opioid Epidemiology and Policy.

Neurology Live (1/31) Research by Orrin Devinsky, MD, professor, Departments of Neurology, Neurosurgery, Psychiatry, director, Comprehensive Epilepsy Center, and colleagues, suggested that an accurate diagnosis of sudden unexplained deaths of toddlers is limited by pathognomonic evidence of terminal seizure because autopsies may be normal or show incidental findings, which he discusses in an interview.

ANI News (IND) (1/31) In a collaboration between researchers at NYU Grossman School of Medicine and scientists at Rocket Pharmaceuticals (a biotechnology company), the new work revealed that untreated mice engineered to lose PKP2 gene function died within six weeks after the gene was silenced, but all but one of those that received a single dose of a gene therapy, carrying the normal version of the gene, lived for more than five months. Study co-lead author Chantal van Opbergen, PhD, postdoctoral research fellow at NYU Langone Health said, Our findings offer experimental evidence that gene therapy targeting plakophilin-2 can interrupt the progression of a deadly heart condition. Study co-senior author Mario Delmar, MD, PhD, the Patricia M. and Robert H. Martinsen Professor of Cardiology, Department of Medicine, professor, Department of Cell Biology said, These results suggest that this gene-therapy method may combat arrhythmogenic right ventricular cardiomyopathy in both early and more advanced stages of the condition. Study co-senior author and cardiologist Marina Cerrone, MD, research associate professor, Department of Medicine at NYU Langone Health, said, Such promising findings in animal models pave the way towards exploring this treatment option in humans. Also reporting is Drug Target Review (UK) (1/31).

Labiotech (1/31) A phase 2b trial was recently conducted in patients with focal epilepsy by researchers at NYU Grossman School of Medicine which showed that patients who added an investigational epilepsy drug, called XEN1101, to their current antiseizure treatments saw a 33% to 53% drop in monthly seizures, depending on their dose. Study lead author Jacqueline A. French, MD, professor, Department of Neurology, Comprehensive Epilepsy Center said in NYU Langone Healths press release, that one of the major benefits of this new drug is that it takes more than a week to break down, so levels in the brain remain consistent over time.

The Consultant Live (1/31) Shoshana H. Ballew, PhD, member of the faculty, Departments of Population Health, and Medicine at New York University Grossman School of Medicine, and colleagues wrote, eGFRcr levels of 60 mL/min/1.73 m2 or lower are less strongly associated with adverse outcomes in older adults than in young persons.

The ASCO Post (1/31) In the phase IIb KEYNOTE-942 trial reported in The Lancet, Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center at NYU Langone Health, and colleagues found that the addition of adjuvant mRNA-4157 a novel mRNA-based individualized neoantigen therapy to pembrolizumab numerically improved recurrence-free survival in patients with completely resected high-risk cutaneous melanoma.

Boston (1/31) The timing of the effects of an edible can vary even for experienced cannabis consumers, because the contents of your stomach affect how quickly an edible kicks in, said Collin Reiff, MD, clinical assistant professor, Department of Psychiatry.

Black Enterprise (1/31) According to Brendan Parent, JD, assistant professor, Department of Population Health, Division of Medical Ethics, and Department of Surgery, Transplant Institute, The idea that the warden of a prison is authorizing the recovery of bodies and of organs without that individuals authorization during their life and without the familys authorization is a total moral failing and probably a legal failing, too.

InStyle (1/31) You want to have the heel of a shoe positioned directly underneath your heel bone, instead of the back of the shoe, which is important because it distributes your weight more evenly, creating a more comfortable shoe overall, says podiatrist and high heel designer Mika Hayashi, DPM, podiatrist at NYU Langone Health a NYU Langone Orthopedic Hospital-affiliated podiatrist and heel designer at Mika Hayashi.

HuffPost (UK) (1/31) Humidifiers can relieve nasal dryness, a dry cough and even dry skin or eczema, Kanwaljit Rupam Brar, MD, associate professor, Department of Pediatrics, Division of Pediatric Allergy & Immunology at New York University Grossman School of Medicine, told HuffPost.

Yahoo! Lifestyle (1/30) In some cases of Crohns, inflammation in the small intestine impairs lactase activity and causes lactose intolerance, Arielle Leben, RD, registered dietician, Inflammatory Bowel Disease Center, told Womens Health.

HerFamily (IRL) (1/31) Researchers at NYU Grossman School of Medicine looked at the brain circuits of a dozen female mice and are believed to have discovered the reason for lactation occurring when the sound of a baby crying is heard, as hearing the sound of a newborns wail can trigger the release of oxytocin, a brain chemical that controls breast milk release in mothers.

The Ottawa Citizen (CAN) (1/31) Although overdose deaths in Oregon have continued to rise since 2020, a recent study led by NYUs Grossman School of Medicine found no link between decriminalization policy and overdose deaths.

Fox News (1/31) Fox News medical contributor Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine of NYU Langone Health on the potential to treat chronic pain and prevent addictions and the latest findings from Alzheimers research.

In a second segment, Fox Business (1/31) medical contributor Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine of NYU Langone Health discusses how prepared hospital ERs are to treat kids and the side effects of weight loss drugs on The Big Money Show.

Omny FM (1/31) In an embedded podcast, Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, joins Megan discussing Artificial Intelligence and if it has the ability to predict when you are going to die.

Well and Good (1/31) Making healthy choices when youre younger is like investing in a 401K, says Allison B. Reiss, MD, associate professor, Departments of Foundations of Medicine, and Medicine, NYU Long Island School of Medicine and a member of the Alzheimers Foundation of America Medical, Scientific & Memory Screening Advisory Board.

Here is the original post:

NYU Langone Health in the NewsThursday, February 1, 2024 - NYU Langone Health